With the analysis among 720 patents, we discovered top 163 key players by total patent application. Arcus Biosciences, Inc., Genentech, Inc., Novartis AG are dominant in this area. They take 23.47% of the total patent filing.
California, United States
Patent: 107
California, United States
Patent: 33
Basel-Stadt, Switzerland
Patent: 29
California, United States
Patent: 25
Pionyr Immunotherapeutics, Inc.
California, United States
Patent: 22
New Jersey, United States
Patent: 21
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Beijing Shi, China
Patent: 19
Synta Pharmaceuticals Corp.
Massachusetts, United States
Patent: 19
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 12
With the analysis among 59 patents, we discovered top 12 start-ups by total patent application. Pionyr Immunotherapeutics, Inc., Institut National de la Santé et de la Recherche Médicale, KOTAI Biotechnologies, Inc. are active in this area.
Pionyr Immunotherapeutics, Inc.
California, United States
Patent: 22
Institut National de la Santé et de la Recherche Médicale
KOTAI Biotechnologies, Inc.
Gyeonggi-do, South Korea
Patent: 6
Lyvgen Biopharma Co., Ltd
Shanghai Shi, China
Patent: 5
Beijing Shenrui Bolian Technology Co., Ltd.
Beijing Shi, China
Patent: 2
Animal Industry Data Korea Co. Ltd.
Octagon Therapeutics, Inc.
Massachusetts, United States
Patent: 1
With the analysis among related 609 patents applied in the last 5 years. We discover 206 most active companies in this area. The fast-growing Arcus Biosciences, Inc., Novartis AG, Pionyr Immunotherapeutics, Inc. take 22.82% of patent filing during this period.
California, United States
Patent: 94
Basel-Stadt, Switzerland
Patent: 23
Pionyr Immunotherapeutics, Inc.
California, United States
Patent: 22
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Beijing Shi, China
Patent: 19
Washington, United States
Patent: 17
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 12
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 12
Shenzhen Chipscreen Biosciences Co., Ltd.
Guangdong Sheng, China
Patent: 10
Osaka-fu, Japan
Patent: 10
With the analysis among related 609 patents in last 5 years, we discover 172 new entrants. Pionyr Immunotherapeutics, Inc., Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Good T Cells Inc are the most active new entrants in this area.
Pionyr Immunotherapeutics, Inc.
California, United States
Patent: 22
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Beijing Shi, China
Patent: 19
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 12
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 12
Osaka-fu, Japan
Patent: 10
Shenzhen Chipscreen Biosciences Co., Ltd.
Guangdong Sheng, China
Patent: 10
Risen Suzhou Pharmacy Tech Co Ltd
Jiangsu Sheng, China
Patent: 10
National Institute of Biomedical Innovation
With the analysis among 227 patents, we discovered top 62 universities and scientific research institutions by total patent application. University of Washington, Osaka University, Okayama University are dominant in this area. They take 24.67% of the total patent filing.
Washington, United States
Patent: 31
Okayama-ken, Japan
Patent: 6
Technical University of Denmark
Hovedstaden, Denmark
Patent: 4
Queen Mary University of London
Antwerpen, Belgium
Patent: 4
National Pingtung University of Science & Technology
Chinese Academy of Medical Scciences & Peking Union Medical College
National University of Singapore
Central Region, Singapore
Patent: 3